ALIIBRU

About this medicine

Indicated for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy; adult patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL); adult patients with CLL/SLL with 17p deletion; adult patients with Waldenström macroglobulinaemia (WM); and adult and paediatric patients aged 1 year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.